Veradigm (NASDAQ:MDRX) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX) in a research report released on Monday. The brokerage issued a hold rating on the software maker’s stock.

Several other equities analysts have also issued reports on MDRX. Royal Bank of Canada cut their target price on Veradigm from $22.00 to $11.00 and set an outperform rating on the stock in a research note on Friday, January 19th. Barclays initiated coverage on shares of Veradigm in a research report on Wednesday, January 3rd. They issued an equal weight rating and a $11.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft reissued a hold rating and set a $10.00 target price (down previously from $15.00) on shares of Veradigm in a research report on Tuesday, March 19th. Five investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of Hold and an average price target of $11.25.

Veradigm Stock Up 1.3 %

Shares of NASDAQ MDRX opened at $7.55 on Monday. Veradigm has a 12-month low of $5.01 and a 12-month high of $14.09. The stock’s fifty day simple moving average is $7.83 and its two-hundred day simple moving average is $10.18.

Institutional Investors Weigh In On Veradigm

Large investors have recently modified their holdings of the business. Bank of New York Mellon Corp boosted its stake in Veradigm by 3.1% in the 1st quarter. Bank of New York Mellon Corp now owns 1,323,414 shares of the software maker’s stock worth $29,803,000 after purchasing an additional 39,210 shares in the last quarter. Citigroup Inc. raised its holdings in shares of Veradigm by 1.8% in the first quarter. Citigroup Inc. now owns 118,927 shares of the software maker’s stock worth $2,678,000 after buying an additional 2,157 shares during the last quarter. Natixis Advisors L.P. lifted its stake in shares of Veradigm by 23.8% during the first quarter. Natixis Advisors L.P. now owns 86,478 shares of the software maker’s stock worth $1,948,000 after buying an additional 16,642 shares during the period. Bank of Montreal Can grew its holdings in shares of Veradigm by 3.6% during the first quarter. Bank of Montreal Can now owns 34,210 shares of the software maker’s stock valued at $768,000 after buying an additional 1,198 shares during the last quarter. Finally, MetLife Investment Management LLC increased its position in shares of Veradigm by 57.0% in the 1st quarter. MetLife Investment Management LLC now owns 68,294 shares of the software maker’s stock valued at $1,538,000 after acquiring an additional 24,794 shares during the period.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.